Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Leckrone ...... question....

"...he has an equity stake of 2.5 million shares ...so therefore to be arbitrary I will pick .30 p/sh or in other words he hypothetically spent a total of 750 million dollars of stock...

2,5mio shares * $0.30 = $750.000

Anyway, I agree with your overall opinion re Leckrone and the lower the shareprice is, the higher the chance for TPL to merge PTSC with Intelaysis.

GLTY

Share
New Message
Please login to post a reply